Bharat Biotech to introduce vaccine against Zika virus

DR. JAY SHINDE | February 8, 2016

article image
Although not heard of very frequently, Zika is a disease brought about by the bite of a Zika virus-infected Aedes species mosquito. The same mosquito is responsible for the spread of diseases such as Chikungunya, yellow fever and dengue.In Zika, the symptoms commence 2-6 days after being bit by the mosquito. These typically include a mild fever, body rashes, joint pain, and conjunctivitis. Since this condition is mild, it often goes unnoticed, and thus not life threatening. There have been a few reported deaths. The disease can be transmitted from an expectant mother to her baby, resulting in severe complications in the new born, or can be transmitted from person through person via the Aedes mosquito as a carrier

Spotlight

Biorad Medisys Pvt Ltd

Biorad Medisys is a leading global specialty manufacturer of a large portfolio of implants and surgical devices . Full-fledged integrated manufacturing facilities in Pune and Bengaluru, adhering to strict GMP are set up, starting its operations almost a decade ago the company operates under stringent guidelines and certified by ISO 13485/IS0 9001-2008. The facilities boast of state of the art machinery imported from UK, Germany & Japan. The company develops and markets innovative technologies and medical products through its two divisions; Orthovasive and Indovasive which are CE certified and partners with healthcare professionals in enhancing patient care.

OTHER ARTICLES

Clinical Supply Availability & Speed to Study Start-Up

Article | March 26, 2020

If you’re part of a clinical study team racing a new product to commercialization, you likely live by these two simple rules: time is money, and the first one to market wins. But just because it’s simple doesn’t mean it’s easy. That ticking clock is background noise to the responsibilities of regulations, study protocols, supply chains, and patient recruitment — all the details that must be worked out before a study can even begin. The pressure is always there. The longer it takes for a study to start, the longer it takes to complete.

Read More

WALGREEN’S IN HOT WATER OVER PHONY PHARMACIST

Article | March 26, 2020

The drugstore chain agreed to pay $7.5 million in fines after an unlicensed pharmacist at several San Francisco Bay locations illegally filled more than 700,000 prescriptions over a ten-year period. According to California prosecutors, Kim Thien Le stole license numbers from other pharmacists to fill prescriptions for Fentanyl, morphine, and other painkillers. Le pleaded guilty to multiple felony impersonation counts. Walgreen’s agreed to the settlement to avoid being charged with consumer fraud in Alameda and Santa Anna Counties. Prosecutors alleged that Walgreen’s failed to verify Le’s license and did not conduct a thorough background check. The company insisted it has taken remedial measures.

Read More

Tips for Managing Chronic Pain Beyond Prescription Painkillers

Article | March 26, 2020

Painkillers like Oxycontin, Percocet, and Vicodin, have been prescribed by primary physicians, surgeons, dentists, and other healthcare providers to patients suffering from varying levels of pain. Though these medications have proven to be an effective source of pain relief, they have also proven to be highly addictive. In fact, it has even been reported that there are more cases of a drug overdose and deaths from prescription painkillers than heroin or cocaine. While there are a number of factors that play into this opioid epidemic, educating doctors and patients on alternative solutions to managing chronic pain is a great place to start combatting this nationwide crisis.

Read More

Decentralized Clinical Trials: Imperative for Pharma Sector to fight COVID19

Article | March 26, 2020

These are unprecedented times. The world is mobbed by a contagion virus, putting people’s health at risk, threatening to destabilize economies. It has already put global healthcare systems under tremendous pressures, and managed to resist efforts to contain it. Even though coronaviruses are not new, this COVID-19 strain has created panic and forced us to be locked down in our homes sans any movement for weeks, if not months. Organizations are fighting an intense battle to keep their workforce safe, minimize risk, and ensure business continuity. For the Life Sciences industry, however, the challenge is even more significant. The whole world is looking at them to come up with a vaccine and a cure. But that is easier said than done. Bringing a new drug to market is an uphill battle and requires rigorous clinical trials. This process already has regulatory challenges. With the current lockdown situation, the Pharma community is grappled with the challenge of continuing some of the critical and time-sensitive in-flight trials so that their regulatory submission, registration, and market entry are not impacted. But all may not be lost. With the right technology solution, it is possible to turn the situation around rapidly.

Read More

Spotlight

Biorad Medisys Pvt Ltd

Biorad Medisys is a leading global specialty manufacturer of a large portfolio of implants and surgical devices . Full-fledged integrated manufacturing facilities in Pune and Bengaluru, adhering to strict GMP are set up, starting its operations almost a decade ago the company operates under stringent guidelines and certified by ISO 13485/IS0 9001-2008. The facilities boast of state of the art machinery imported from UK, Germany & Japan. The company develops and markets innovative technologies and medical products through its two divisions; Orthovasive and Indovasive which are CE certified and partners with healthcare professionals in enhancing patient care.

Events